基于T2加权成像与动态对比增强磁共振成像的影像组学和人工智能分析预测乳腺癌组织学结局
研究纳入217例接受MRI检查的恶性乳腺病变患者,以组织学结果为金标准,采用影像组学特征结合人工智能方法预测乳腺癌组织学结局。基于早期T1加权减影图像和决策树区分HER2阳性与阴性乳腺癌的验证集准确率为88%,区分管腔型与非管腔型的验证集准确率为94%。作者认为影像组学分析联合人工智能技术可能有助于支持医生预测乳腺癌组织学结局的决策。
要点
- 基于早期T1加权减影图像和决策树的模型区分HER2阳性与阴性乳腺癌的验证集准确率为88%。
- 基于T2加权减影图像和决策树的模型区分激素受体阳性与阴性乳腺癌的验证集准确率为90%。
- 基于早期T1加权减影图像和决策树的模型区分管腔型与非管腔型乳腺癌的验证集准确率为94%。
核心结论
- 影像组学分析联合人工智能技术可能有助于支持医生预测乳腺癌组织学结局的决策。
研究设计与样本
- 研究纳入217例接受MRI检查的恶性乳腺病变患者,以组织学结果为金标准,采用单因素和多因素分析评估MRI影像组学特征预测乳腺癌组织学结局的准确性。
关键影像表现/征象
- 基于早期T1加权减影图像的9个预测因子和决策树区分HER2阳性与阴性乳腺癌,验证集准确率为88%。
- 基于T2加权减影图像的9个预测因子和决策树区分激素受体阳性与阴性乳腺癌,验证集准确率为90%。
- 基于早期T1加权减影图像的16个预测因子和线性回归模型区分G1+G2与G3乳腺癌,准确率为75%。
- 基于早期T1加权减影图像的27个预测因子和决策树区分管腔型与非管腔型乳腺癌,验证集准确率为94%。
诊断标准与关键数值
- HER2阳性与阴性分类:基于早期T1加权减影图像的9个预测因子和决策树,验证集准确率为88%。
- 激素受体阳性与阴性分类:基于T2加权减影图像的9个预测因子和决策树,验证集准确率为90%。
- G1+G2与G3分类:基于早期T1加权减影图像的16个预测因子和线性回归模型,准确率为75%。
- 管腔型与非管腔型分类:基于早期T1加权减影图像的27个预测因子和决策树,验证集准确率为94%。
临床应用与阅片要点
- 作者认为影像组学分析联合人工智能技术可能有助于支持医生预测乳腺癌组织学结局的决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of the study was to evaluate the accuracy of radiomics features obtained by MR images to predict Breast Cancer Histological Outcome.
METHODS: A total of 217 patients with malignant lesions were analysed underwent MRI examinations. Considering histological findings as the ground truth, four different types of findings were used in both univariate and multivariate analyses: (1) G1 + G2 vs G3 classification; (2) presence of human epidermal growth factor receptor 2 (HER2 + vs HER2 -); (3) presence of the hormone receptor (HR + vs HR -); and (4) presence of luminal subtypes of breast cancer.
RESULTS: The best accuracy for discriminating HER2 + versus HER2 - breast cancers was obtained considering nine predictors by early phase T1-weighted subtraction images and a decision tree (accuracy of 88% on validation set). The best accuracy for discriminating HR + versus HR - breast cancers was obtained considering nine predictors by T2-weighted subtraction images and a decision tree (accuracy of 90% on validation set). The best accuracy for discriminating G1 + G2 versus G3 breast cancers was obtained considering 16 predictors by early phase T1-weighted subtraction images in a linear regression model with an accuracy of 75%. The best accuracy for discriminating luminal versus non-luminal breast cancers was obtained considering 27 predictors by early phase T1-weighted subtraction images and a decision tree (accuracy of 94% on validation set).
CONCLUSIONS: The combination of radiomics analysis and artificial intelligence techniques could be used to support physician decision-making in prediction of Breast Cancer Histological Outcome.
引用
- Petrillo A, Fusco R, Barretta ML, et al. Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict Breast Cancer Histological Outcome. Radiol Med. 2023. PMID: 37801198. doi:10.1007/s11547-023-01718-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。